Literature DB >> 15282393

Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection.

R A M Breen1, C J Smith, H Bettinson, S Dart, B Bannister, M A Johnson, M C I Lipman.   

Abstract

BACKGROUND: It has been suggested that deterioration of tuberculosis (TB) during appropriate treatment, termed a paradoxical reaction (PR), is more common and severe in HIV positive individuals on highly active antiretroviral therapy (HAART).
METHOD: A study was undertaken to determine the frequency of PR and its associated features in a population of HIV+TB+ patients and a similar sized group of HIV-TB+ individuals.
RESULTS: PR occurred in 28% of 50 HIV+TB+ patients and 10% of 50 HIV-TB+ patients. Disseminated TB was present in eight of 13 HIV+TB+ patients and four of five HIV-TB+ patients with PR. In 28 HIV+TB+ patients starting HAART, PR was significantly associated with commencing HAART within 6 weeks of starting antituberculosis treatment (p = 0.03) and was more common in those with disseminated TB (p = 0.09). No association was found between development of PR and baseline CD4 count or CD4 response to HAART.
CONCLUSIONS: PR is common in HIV infected and uninfected individuals with TB. Early introduction of HAART and the presence of disseminated TB appear to be important in co-infected patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282393      PMCID: PMC1747098          DOI: 10.1136/thx.2003.019224

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  16 in total

1.  Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy.

Authors:  Enrique Navas; Pilar Martín-Dávila; Leonor Moreno; Vicente Pintado; José L Casado; Jesús Fortún; María J Pérez-Elías; Enrique Gomez-Mampaso; Santiago Moreno
Journal:  Arch Intern Med       Date:  2002-01-14

2.  Transitory exacerbation of fever and roentgenographic findings during treatment of tuberculosis in children.

Authors:  C B CHOREMIS; C PADIATELLIS; D ZOU MBOU LAKIS; D YANNAKOS
Journal:  Am Rev Tuberc       Date:  1955-10

3.  Further observations on tuberculin reactions in active tuberculosis.

Authors:  J J Rooney; J A Crocco; S Kramer; H A Lyons
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

4.  Paradoxical worsening of tuberculosis in HIV-infected persons.

Authors:  K A Wendel; K S Alwood; R Gachuhi; R E Chaisson; W R Bishai; T R Sterling
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

5.  Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy.

Authors:  Neil W Schluger; Daniel Perez; Yuk Ming Liu
Journal:  Chest       Date:  2002-08       Impact factor: 9.410

6.  Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature.

Authors:  J K Onwubalili; G M Scott; H Smith
Journal:  Q J Med       Date:  1986-06

7.  Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects.

Authors:  S M Barry; M C I Lipman; A R Deery; M A Johnson; G Janossy
Journal:  HIV Med       Date:  2002-07       Impact factor: 3.180

8.  Impact of HIV on tuberculosis in Zambia: a cross sectional study.

Authors:  A M Elliott; N Luo; G Tembo; B Halwiindi; G Steenbergen; L Machiels; J Pobee; P Nunn; R J Hayes; K P McAdam
Journal:  BMJ       Date:  1990-09-01

9.  Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis.

Authors:  Simon M Barry; Marc C Lipman; Barbara Bannister; Margaret A Johnson; George Janossy
Journal:  J Infect Dis       Date:  2002-12-19       Impact factor: 5.226

10.  Lymph node tuberculosis: a comparison of various methods of treatment.

Authors:  I A Campbell; A J Dyson
Journal:  Tubercle       Date:  1977-12
View more
  97 in total

1.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

Review 2.  Management of the immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; James Scriven; Suzaan Marais
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

3.  Immune reconstitution inflammatory syndrome.

Authors:  M S Barthwal; Yadvir Garg; D Bhattacharya; C D S Katoch; A K Rajput; V Marwah
Journal:  Med J Armed Forces India       Date:  2014-10-08

4.  An unusual case of sepsis? A rare presentation of a common disease.

Authors:  Christopher Myles Rowe; Nishita Desai; Rachel Coathup; Magda Cepkova
Journal:  BMJ Case Rep       Date:  2015-08-21

5.  Isolated ocular Jarisch-Herxheimer reaction after initiating tuberculostatic therapy in a child.

Authors:  Henrike Neunhöffer; Annika Gold; Hans Hoerauf; Carl Herbort; Arnd Heiligenhaus; Ortrud Zimmermann; Nicolas Feltgen
Journal:  Int Ophthalmol       Date:  2014-06       Impact factor: 2.031

6.  Immune reconstitution syndrome in a child with TB and HIV.

Authors:  G Narendran; Soumya Swaminathan; S Sathish; S Rajasekaran
Journal:  Indian J Pediatr       Date:  2006-07       Impact factor: 1.967

Review 7.  Management of patients with HIV in the intensive care unit.

Authors:  Henry Masur
Journal:  Proc Am Thorac Soc       Date:  2006

8.  High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.

Authors:  Susan E Dorman; Payam Nahid; Ekaterina V Kurbatova; Stefan V Goldberg; Lorna Bozeman; William J Burman; Kwok-Chiu Chang; Michael Chen; Mark Cotton; Kelly E Dooley; Melissa Engle; Pei-Jean Feng; Courtney V Fletcher; Phan Ha; Charles M Heilig; John L Johnson; Erica Lessem; Beverly Metchock; Jose M Miro; Nguyen Viet Nhung; April C Pettit; Patrick P J Phillips; Anthony T Podany; Anne E Purfield; Kathleen Robergeau; Wadzanai Samaneka; Nigel A Scott; Erin Sizemore; Andrew Vernon; Marc Weiner; Susan Swindells; Richard E Chaisson
Journal:  Contemp Clin Trials       Date:  2020-01-22       Impact factor: 2.226

9.  Disseminated tuberculous lymphadenitis presenting as cervical mass in patient with HIV infection, worsening after antiretroviral initiation: diagnosis and treatment challenges.

Authors:  Alain Bruno Tagne Nouemssi
Journal:  BMJ Case Rep       Date:  2018-03-15

10.  Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.

Authors:  Humphrey J Shao; John A Crump; Habib O Ramadhani; Leonard O Uiso; Sendui Ole-Nguyaine; Andrew M Moon; Rehema A Kiwera; Christopher W Woods; John F Shao; John A Bartlett; Nathan M Thielman
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.